Shay Misch – Vice President Business Development

Mr. Shay Misch has served as VP Strategy and Business Development since July 2012. Prior to joining ICL Mr. Misch served as CFO of Neopharm Group. Before that he served as Director of Business Development and global merger and acquisition activity at Teva Pharmaceuticals. Mr. Misch worked also at PwC corporate finance department. Mr. Misch holds an M.B.A. from Tel Aviv University and L.L.B in law from Tel Aviv University.